Health and Medical Devices News
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
WATERTOWN, Mass.--(BUSINESS WIRE)--Iluvien receives priority review from FDA
…
Bruker to Ring NASDAQ Opening Bell on Company’s 50th Anniversary
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that its management team will ring the Opening Bell at the NASDAQ Stock Market on Tuesday, September 7, 2010 at 9:30 a.m. EDT at the NASDAQ MarketSite in New York City’s Times Square. Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial, clinical and applied analysis. Dr. Frank Laukien, Bruker’s President
…
DexCom Announces Resignation of Donald A. Lucas as Board Member
SAN DIEGO--(BUSINESS WIRE)--DexCom announces resignation of Donald A. Lucas as board member.
…
Furiex Pharmaceuticals, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York September 12-15, 2010
MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) announced today that it will present at Rodman & Renshaw’s 12th Annual Healthcare Conference in New York on Monday, September 13, 2010, at 2:50 p.m. ET. Dr. Fred Eshelman, the company’s chairman, will provide a corporate overview and discuss Furiex’s pipeline. A live webcast of the presentation will be available on the Rodman & Renshaw website. An archived recording of the presentation will also be available
…
Teleflex to Present at the Morgan Stanley Global Healthcare Conference
LIMERICK, Pa.--(BUSINESS WIRE)--Jeffrey P. Black, Chairman and Chief Executive Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley Global Healthcare Conference at The Grand Hyatt in New York City, Monday, September 13, 2010 at 3:20 p.m. (ET). An audio webcast including the slide presentation will be available on the investor portion of the Teleflex website at www.teleflex.com. About Teleflex Incorporated Teleflex is a global provider of medical technology prod
…
Impact of Health Reform, Emerging Care Models Explored at GE Healthcare IT National Users’ Conference
BOSTON--(BUSINESS WIRE)--Industry changes are top of mind for executives at hospitals, medical colleges and hospital networks across the United States and will be actively discussed at this week’s GE Centricity® Business National Users’ Conference. A record number of Centricity Business customers are in Boston for the summit, hosted by GE Healthcare August 30-31 at the Sheraton Boston Hotel and Fairmont Copley Plaza. Nearly 600 customers representing 180 unique healthcare organizations are atten
…
Z-Medica Signs Distribution Agreement with Nihon-Kohden
WALLINGFORD, Conn.--(BUSINESS WIRE)--Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed an exclusive distribution agreement with Nihon-Kohden, Japan's leading manufacturer, developer and distributor of medical electronic equipment . The agreement allows Nihon-Kohden the exclusive right to distribute Z-Medica’s QuikClot line of hemostatic agents to hospital, military and law enforcement markets throughout Japan. The companies
…
Research and Markets: The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/895218/the_top_10_cardiov) has announced the addition of the "The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses" report to their offering. The cardiovascular (CV) device industry is highly competitive and has reached maturity resulting in single digit growth rates of prominent devices such as pacemakers, defibrillators, and drug eluting stents (DES). Innovations
…
A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefront
INGELHEIM, Germany--(BUSINESS WIRE)--The European Society of Cardiology (ESC) today issued revised practice guidelines for the management of atrial fibrillation (AF), including guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). At the same time, Boehringer Ingelheim confirms that the U.S. Food and Drug Administration (FDA) granted a priority review designation for Boehringer Ingelheim
…
Research and Markets: Argentina Surgical Equipment Market Outlook to 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/60ef74/argentina_surgical) has announced the addition of GlobalData's new report "Argentina Surgical Equipment Market Outlook to 2016" to their offering. Argentina Surgical Equipment Market Outlook to 2016 Summary Our medical devices report, Argentina Surgical Equipment Market Outlook to 2016 provides key market data on the Argentina Surgical Equipment market. The report provides value (USD million), volume
…
Biomagnetics Announces LOI to Acquire Lanzhou New Sunshine Plastics Industry LTD Fourth Chinese Asset Targeted at $1.50 BMGP Share Price
SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou New Sunshine Plastics Industry LTD. This expected acquisition is the fourth planned acquisition targeted at a share price of US $1.50 for Biomagnetics Diagnostics’ common shares. Under the terms
…
Welch Allyn Offers Company’s First End-to-End Customer Service Program
SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn today introduced a holistic customer service plan based on three main tenets—-support, education and professional services.
…
Vitrolife: New study shows improved survival with Perfadex
STOCKHOLM--(BUSINESS WIRE)--A recently published study in The Journal of Heart and Lung Transplantation shows that the patients who are most seriously ill before lung tranplantation have better one-year survival when Perfadex is used as the preservation solution for donor lungs compared with UW solution. Furthermore, the patients who received lungs preserved in Perfadex ran a significantly lower risk of being affected by rejection reactions requiring treatment. Researchers at the John Hopkins in
…
Aptus Endosystems Completes $15 Million Series AA Financing
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced the completion of a $15 million Series AA financing.
…
Covidien Completes Sale of Specialty Chemicals Business
DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million. The decision to divest Specialty Chemicals was made following a thorough evaluation of a number of strategic alternatives. The decision is consistent with Covidien’s strategy to streamline its p
…
AngioDynamics Expands Its VenaCure EVLTTM System to Offer Physicians Fewer Procedure Steps and a Faster Procedure Time
ALBANY, N.Y.--(BUSINESS WIRE)--AngioDynamics announced the launch of a new access kit allowing fewer steps, faster procedure time for doctors using the VenaCure EVLT system’s NeverTouch® gold-tip laser fiber to treat varicose veins
…
Toshiba Installs 1,000th MR System Worldwide
TUSTIN, Calif.--(BUSINESS WIRE)--Diagnostic imaging leader Toshiba America Medical Systems, Inc. has installed its 1,000th MR system worldwide. Kosair Children’s Medical Center – Brownsboro, the only pediatric outpatient facility of its type in Kentucky, is the site of Toshiba’s milestone installation. The new facility, dedicated to the care of children, is located in the eastern suburbs of Louisville, Ky., and is the newest addition to Kosair Children’s Hospital and the Norton Healthcare Networ
…
EndoGastric Solutions Completes $30 Million Financing Round
REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions announces completing $30M Financing Round
…
KIKA Clinical Solutions Releases Veracity™ 3.10, Newest Version of its Advanced EDC Platform for Clinical Trial Management
BOSTON & PARIS--(BUSINESS WIRE)--KIKA™ Clinical Solutions announced Veracity™ 3.10, the latest release of its market-leading, advanced EDC platform. 3.10 includes enhancements in Document Management,Query Monitoring,DICOM imaging.
…
アルコン独立取締役委員会が、ノバルティスによるネスレ保有アルコン株式の取得完了について見解を発表
スイス・ヒューネンベルク--(BUSINESS WIRE)--（ビジネスワイヤ） -- アルコン独立取締役委員会（IDC）は、ノバルティスがネスレ所有の残りのアルコン株式の取得を完了したことについて見解を発表しました。この取引は2008年4月6日にネスレとノバルティスとの間で結ばれた買い取りおよびオプション契約に基づいて完了し、ノバルティスが所有するアルコン株式は約77パーセントに増加しました。ネスレとノバルティスとの取引の完了は予想されていた出来事であり、ノバルティスが少数株主に提示している合併案に対するIDCの立場に影響を及ぼすものではありません。 独立取締役委員会のトーマス・G・プラスケット委員長は、次のように述べています。「私たちは、アルコンの少数株主に公正な価格を提示する取引についての交渉を期待しています。合意による取引はすべての関係者の最大の利益であり、統合の重要な段階を遅らせることになる長期的な訴訟よりも望ましいことは明らかです。しかし、ノバルティスが公正な取引の交渉を拒否する場合には、私たちはアルコンおよびその少数株主の権利を守ります。」 ネスレとノバルティスの取引が完
…
